How to evaluate Stock solution stability according to EMA guideline [Bioanalytics]

posted by chandru – India, 2018-05-27 23:26 (2540 d 17:13 ago) – Posting: # 18819
Views: 3,553

Hi Ohlbe,

Is it ok to evaluate working solution stability according to FDA guidance May 2018 at LQC and HQC level.

As they have spoken about stock solution stability which has to be done at LQC and HQC level. Does it apply for working solution stability?


Thanks,
Chandru

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
111 visitors (0 registered, 111 guests [including 7 identified bots]).
Forum time: 16:39 CEST (Europe/Vienna)

Lack of clarity is always a sign of dishonesty.    Celia Green

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5